This well-known phenomenon is mediated by steroid hormones and by the anti-insulin action of placental tissues [32], which in turn can modulate insulin signalling, glucose transport and peroxisome proliferator-activated receptor (PPAR) function [33,34], which placenta expression has been directly associated with GDM in female population [35]. This evidence concerns the gene INS and gestational diabetes.